Prostate Cancer Home > Flutamide Product Information

Flutamide (Eulexin®) is a medicine approved for the treatment of prostate cancer. Specifically, it is approved to treat Stage IIB to III (Stages B2 to C) and Stage IV (Stage D2). This medicine is always combined with another product: a gonadotropin-releasing hormone agonist. Together, the two drugs affect the production and action of testosterone, which inhibits the growth of cancer cells.
It is important to review the safety information for this product before beginning treatment with flutamide. For example, your healthcare provider needs to know about any allergies you may have and any other drugs or supplements you are taking.
(Click Flutamide for more information on this product, including possible side effects, dosing guidelines, and generic availability.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Topics & Medications


Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.